Data Presented at ISSCR 2026 Highlight Progress Toward Personalized Stem Cell Therapy for Parkinson’s Disease
Today at the ISSCR 2026 Annual Meeting, Jeanne Loring, Ph.D., Scripps Research, USA, will present interim clinical findings from the first Phase 1/2a trial using autologous induced pluripotent stem…
Read the full articleYou might also wanna read
Pulse Security Debuts Operational Management Platform Built for Security Leaders
NextBigFuture·1h ago
Insignary Launches Clarity On-Demand: SBOMs, No Annual Commitment Required
NextBigFuture·2h ago
Nearly 500,000 Comments Submitted in Response to Trump Administration’s Proposal to Insert Politics into Federal Funding
environmentalprotectionnetwork.org·18h ago
Tego AI Finds Claude Tag Slack Integration Can Trigger Unauthorized Enterprise Actions
NextBigFuture·22h ago
Greenhat Announces Successful Delegation at Web Summit Vancouver 2026
NextBigFuture·1d ago
PSI Colorado Office Celebrates 10 Years
psi.edu·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.